THE LONG-TERM SAFETY AND EFFICACY OF TADALAFIL 5MG ONCE-DAILY IN MEN WITH LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS)

被引：0
|
作者：
Donatucci, C. [1 ]
Brock, G. [2 ]
Goldfischer, E. [3 ]
Pommerville, P. [4 ]
Elion-Mboussa, A. [5 ]
Kissel, J. [5 ]
Viktrup, L. [5 ]
机构：
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA
[2] Univ Western Ontario, Dept Surg, St Josephs Hlth Care London, London, ON N6A 3K7, Canada
[3] Hudson Valley Urol, Ctr Poughkeepsie, Poughkeepsie, NY USA
[4] Can Med Clin Res Inc, Victoria, BC, Canada
[5] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60973-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [1] The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)
    Roehrborn, CG
    McVary, KT
    Kaminetsky, JC
    Auerbach, SM
    Wachs, B
    Young, JM
    Esler, A
    Sides, GD
    Denes, BS
    JOURNAL OF UROLOGY, 2006, 175 (04): : 527 - 527
  • [2] The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 196 - 196
  • [3] Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction
    Brock, Gerald
    Broderick, Gregory
    Roehrborn, Claus G.
    Xu, Lei
    Wong, David
    Viktrup, Lars
    BJU INTERNATIONAL, 2013, 112 (07) : 990 - 997
  • [4] The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis
    Lee, Sung Won
    Paick, Jae Seung
    Park, Hyun Jun
    Won, Ji Eon
    Morisaki, Yoji
    Sorsaburu, Sebastian
    Viktrup, Lars
    WORLD JOURNAL OF MENS HEALTH, 2014, 32 (01): : 28 - 35
  • [5] Efficacy and Safety of the Coadministration of Tadalafil Once Daily with Finasteride for 6 Months in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
    Casabe, Adolfo
    Roehrborn, Claus G.
    Da Pozzo, Luigi F.
    Zepeda, Sebastian
    Henderson, R. Jonathan
    Sorsaburu, Sebastian
    Henneges, Carsten
    Wong, David G.
    Viktrup, Lars
    JOURNAL OF UROLOGY, 2014, 191 (03): : 727 - 733
  • [6] EFFICACY AND SAFETY OF TADALAFIL 5 MG ONCE DAILY IN ASIAN MALES WITH LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS): INTEGRATED ANALYSIS FROM 3 ASIAN DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL STUDIES
    Takeda, M.
    Murakami, M.
    Morisaki, Y.
    Viktrup, L.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (06) : 967 - 969
  • [7] Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil
    Park, Hyun Jun
    Won, Ji Eon Joanne
    Sorsaburu, Sebastian
    Rivera, Paul David
    Lee, Seung Wook
    WORLD JOURNAL OF MENS HEALTH, 2013, 31 (03): : 193 - 207
  • [8] The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (Luts) in men with benign prostatic hyperplasia (BPH) (vol 4, pg S91, 2007)
    Young, J. M.
    Roehrborn, C. G.
    McVary, K. T.
    Kaminetsky, J. C.
    Auerbach, S. M.
    Wachs, B.
    Esler, A.
    Sides, G. D.
    Denes, B. S.
    JOURNAL OF SEXUAL MEDICINE, 2007, 4 (02): : 522 - 522
  • [9] A practical primary care approach to lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH-LUTS)
    Rosenberg, Matt T.
    Witt, Erik S.
    Miner, Martin
    Barkin, Jack
    CANADIAN JOURNAL OF UROLOGY, 2014, 21 : 12 - 24
  • [10] EFFECT OF TADALAFIL ONCE DAILY ON PROSTATE BLOOD FLOW AND PERFUSION IN MEN WITH LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS): A RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED TRIAL
    Pinggera, G.
    Frauscher, F.
    Paduch, D. A.
    Bolyakov, A.
    Efros, M.
    Kaminetsky, J.
    Da Pozzo, L.
    Esler, A.
    Cox, D.
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 252 - 252
12345